Skip to main content
. 2022 Feb 12;143:105284. doi: 10.1016/j.compbiomed.2022.105284

Table 1.

Dataset description for Model development, internal and external validation.

Dataset COVID-19 Non-COVID Total
aTraining (80% of OSR) Italy (OSR) 629 670 1299
aBalanced Training Set 670 670 1340
aInternal validation (20% of OSR) 157 168 325
External validation Italy-1 163 174 337
Italy-2 104 145 249
Italy-3 118 106 224
Brazil-1 352 949 1301
Brazil-2 334 11 345
Ethiopia 200 200
a

Five-fold cross validation was used for performance evaluation. Number of samples per fold for training, augmented training, and internal validation is reported here.